Clinical Outcomes by Race in Hypertensive Patients With and Without the Metabolic Syndrome<subtitle>Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)</subtitle>

2008 Archives of Internal Medicine 111 citations

Abstract

The ALLHAT findings fail to support the preference for calcium channel blockers, alpha-blockers, or angiotensin-converting enzyme inhibitors compared with thiazide-type diuretics in patients with the MetS, despite their more favorable metabolic profiles. This was particularly true for black participants.

Keywords

SubtitleMedicineInternal medicineCardiology

Affiliated Institutions

Related Publications

Publication Info

Year
2008
Type
article
Volume
168
Issue
2
Pages
207-207
Citations
111
Access
Closed

External Links

Citation Metrics

111
OpenAlex

Cite This

Jackson T. Wright (2008). Clinical Outcomes by Race in Hypertensive Patients With and Without the Metabolic Syndrome<subtitle>Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)</subtitle>. Archives of Internal Medicine , 168 (2) , 207-207. https://doi.org/10.1001/archinternmed.2007.66

Identifiers

DOI
10.1001/archinternmed.2007.66